Anne Fåne
Position: Research associate, Msc
Phone: +47 22 78 23 18


2009 – 2010: Master in Biomedical Sciences (James Cook University, Australia), "Oxidative stress and inflammatory cytokines in Burkholderia pseudomallei-induced sepsis"

2005 – 2008: Bachelor in biology (University of Kristiansand, Norway)

2004 – 2005: Molecular Biology (University of Bergen, Norway)

Research interests/projects:

  • Immunotherapy
    • Therapeutic TCRs
    • Chimeric Antigen Receptors (CAR)
      • Cloning, expression, functional testing etc.

Work experience

2014 – Present: Research Engineer at Department of Cellular Therapy, Oslo University Hospital, Norway

2011 – 2013: Microbiology and Immunology Research Assistant at James Cook University, Townsville, Australia


Publications 2017

Morris JL, Fane A, Sarovich DS, Price EP, Rush CM, Govan BL, Parker E, Mayo M, Currie BJ, Ketheesan N (2017)
Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, Australia
Emerg Infect Dis, 23 (5)
PubMed 28418830

Walseng E, Köksal H, Sektioglu IM, Fåne A, Skorstad G, Kvalheim G, Gaudernack G, Inderberg EM, Wälchli S (2017)
A TCR-based Chimeric Antigen Receptor
Sci Rep, 7 (1), 10713
PubMed 28878363

Publications 2016

Batzloff MR, Fane A, Gorton D, Pandey M, Rivera-Hernandez T, Calcutt A, Yeung G, Hartas J, Johnson L, Rush CM, McCarthy J, Ketheesan N, Good MF (2016)
Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate
Hum Vaccin Immunother, 12 (12), 3089-3096
PubMed 27541593

Eide HA, Halvorsen AR, Sandhu V, Fåne A, Berg J, Haakensen VD, Kure EH, Brustugun OT, Kiserud CE, Kyte JA, Helland Å (2016)
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease
Clin Transl Immunology, 5 (11), e109
PubMed 27990285

Kyte JA, Gaudernack G, Faane A, Lislerud K, Inderberg EM, Brunsvig P, Aamdal S, Kvalheim G, Wälchli S, Pule M (2016)
T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy
Oncoimmunology, 5 (12), e1249090
PubMed 28123886

McNeilly C, Cosh S, Vu T, Nichols J, Henningham A, Hofmann A, Fane A, Smeesters PR, Rush CM, Hafner LM, Ketheesan N, Sriprakash KS, McMillan DJ (2016)
Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate
PLoS One, 11 (6), e0156639
PubMed 27310707

Publications 2015

Morris J, Fane A, Rush C, Govan B, Mayo M, Currie BJ, Ketheesan N (2015)
Neurotropic threat characterization of Burkholderia pseudomallei strains
Emerg Infect Dis, 21 (1), 58-63
PubMed 25530166